Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome
Cancer Cell · 2026-11 · 44 (11) · 2324-2325
DOI: 10.1016/j.ccell.2026.10.008 ↗Kurz gefasst
Korrektur in der Zeitschrift Cancer Cell, 2026-11. Verfasst von Maurice Labuhn und 33 weiteren Autor:innen.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Myeloid leukemia in Down syndrome (ML-DS) clonally evolves from transient abnormal myelopoiesis (TAM), a preleukemic condition in DS newborns. To define mechanisms of leukemic transformation, we combined exome and targeted re-sequencing of 111 TAM and 141 ML-DS samples with functional analyses. TAM requires trisomy 21 and truncating mutations in GATA1 ; additional TAM variants are usually not pathogenic. By contrast, in ML-DS, clonal and subclonal variants are functionally required. We identified a recurrent and oncogenic hotspot gain-of-function mutation in myeloid cytokine receptor CSF2RB . By a multiplex CRISPR-Cas9 screen in an in vivo murine TAM model we tested loss-of-function of 22 recurrently mutated ML-DS genes. Loss of 18 different genes produced leukemias that phenotypically, genetically and transcriptionally mirrored ML-DS. demonstrates the importance of functional interrogation of variants, even in genes recurrently mutated in malignancy. Using a functional genomics approach, we defined genetic lesions acquired in ML-DS that induce transformation providing a basis to develop refined treatment approaches. Our work also exemplifies a general approach to study transformation from a precursor cancerous lesion. T-3775440 Transdifferentiation Growth of Cells.
Zitieren
APA
Labuhn, M., Perkins, K., Matzk, S., Varghese, L., Garnett, C., Papaemmanuil, E., Metzner, M., Kennedy, A., Amstislavskiy, V., Risch, T., Bhayadia, R., Samulowski, D., Hernandez, D. C., Stoilova, B., Iotchkova, V., Oppermann, U., Scheer, C., Yoshida, K., Schwarzer, A., …, & Klusmann, J. H. (2026). Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome. Cancer Cell, 44(11), 2324-2325. https://doi.org/10.1016/j.ccell.2026.10.008
Vancouver
Labuhn M, Perkins K, Matzk S, Varghese L, Garnett C, Papaemmanuil E, et al. Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome. Cancer Cell. 2026;44(11):2324-2325. doi:10.1016/j.ccell.2026.10.008
BibTeX
@article{Labuhn2026,
author = {Labuhn, Maurice and Perkins, Kelly and Matzk, Sören and Varghese, Leila and Garnett, Catherine and Papaemmanuil, Elli and Metzner, Marlen and Kennedy, Alison and Amstislavskiy, Vyacheslav and Risch, Thomas and Bhayadia, Raj and Samulowski, David and Hernandez, David Cruz and Stoilova, Bilyana and Iotchkova, Valentina and Oppermann, Udo and Scheer, Carina and Yoshida, Kenichi and Schwarzer, Adrian and Taub, Jeffrey W and Crispino, John D and Weiss, Mitchell J and Hayashi, Yasuhide and Taga, Takashi and Ito, Etsuro and Ogawa, Seishi and Reinhardt, Dirk and Yaspo, Marie-Laure and Campbell, Peter J and Roberts, Irene and Constantinescu, Stefan N and Vyas, Paresh and Heckl, Dirk and Klusmann, Jan-Henning},
title = {Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome},
journal = {Cancer Cell},
year = {2026},
volume = {44},
number = {11},
pages = {2324--2325},
doi = {10.1016/j.ccell.2026.10.008}
}
EUVIMED